Skip to main content

Market Overview

38 Stocks Moving In Tuesday's Mid-Day Session

Share:

Gainers

  • RiceBran Technologies (NASDAQ: RIBT) shares jumped 60.8% to $1.4950. RiceBran Technologies is scheduled to host a conference call on April 28th to discuss its Q1 financial results.
  • Tian Ruixiang Holdings Ltd (NASDAQ: TIRX) shares jumped 33.1% to $16.00 after the company reported its financial results for the fiscal year ended October 31, 2020.
  • NetSol Technologies, Inc. (NASDAQ: NTWK) gained 25.3% to $5.40 after the company announced it signed a five-year contract worth multi-million-dollar renewal with a Japanese automotive customer in APAC.
  • Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) shares jumped 24.9% to $13.86 after the company announced positive top-line results from the Phase 3 INVIGORATE study of 0.25% reproxalap ophthalmic solution, an investigational new drug, in patients with allergic conjunctivitis. The clinical trial successfully achieved statistical significance for the primary endpoint and all secondary endpoints, it added.
  • First Choice Bancorp (NASDAQ: FCBP) gained 24% to $30.12 after the company reported a rise in Q1 earnings.
  • The Aaron's Company, Inc. (NYSE: AAN) surged 22% to $32.24 after the company reported better-than-expected Q1 results.
  • Trueblue Inc (NYSE: TBI) rose 22% to $28.10 after the company swung to a Q1 profit.
  • Vaxart, Inc. (NASDAQ: VXRT) gained 18.3% to $7.17.
  • Mechanical Technology, Incorporated (NASDAQ: MKTY) shares gained 16.7% to $9.04 after the company priced its 2,419,355 share common stock offering at $6.20 per unit, for proceeds of $15 million.
  • DermTech, Inc. (NASDAQ: DMTK) surged 15.9% to $47.72 after the company announced the launch DermTech PLAplusTM, its test for the enhanced early detection of melanoma.
  • Heidrick & Struggles International, Inc. (NASDAQ: HSII) jumped 15% to $43.37 after the company reported better-than-expected Q1 results and issued Q2 sales guidance above estimates.
  • Crocs, Inc. (NASDAQ: CROX) gained 15% to $97.66 after the company reported better-than-expected Q1 results. Crocs said it sees Q2 sales growth of 60%-70% and FY21 sales growth of 40%-50%.
  • Corporación América Airports S.A. (NYSE: CAAP) rose 13.5% to $5.90.
  • Cerecor Inc. (NASDAQ: CERC) surged 13.4% to $2.96.
  • Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 13.4% to $3.1794. Arcadia Biosciences recently received Health Canada approval for GoodHemp Varieties.
  • Cullinan Oncology, Inc. (NASDAQ: CGEM) shares rose 13% to $35.80. Morgan Stanley upgraded Cullinan Oncology from Equal-Weight to Overweight.
  • Aravive, Inc. (NASDAQ: ARAV) surged 12.2% to $6.05 as the company said first patient was dosed in Phase 3 registrational trial evaluating AVB-500 in patients with platinum resistant ovarian cancer.
  • United Parcel Service, Inc. (NYSE: UPS) gained 11.3% to $195.67 after the company reported better-than-expected Q1 results.
  • Turning Point Brands, Inc. (NYSE: TPB) jumped 9% to $52.93 after reporting strong quarterly sales.

Check out these big penny stock gainers and losers

Losers

  • Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares dipped 25% to $2.31 after the company priced an underwritten public offering of 3.18 million units at a public offering price of $4.15 per unit for aggregate gross proceeds of approximately $13.2 million. In connection with the offering, the company has received approval to list its common stock and warrants on the Nasdaq Capital Market.
  • RealNetworks, Inc. (NASDAQ: RNWK) fell 22.9% to $2.6301 after the company priced 8.25 million shares at $2.7 per share to raise $22.3 million in a secondary public offering.
  • Sol-Gel Technologies Ltd. (NASDAQ: SLGL) dropped 19.2% to $11.10 after the company issued an update on FDA review of EPSOLAY.
  • Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) dropped 17.2% to $7.20. Reviva Pharmaceuticals shares jumped 104% on Monday after the company announced the full details of its Phase 2 trial evaluating its lead drug candidate, RP5063 (brilaroxazine), for Acute Schizophrenia. Brilaroxazine demonstrated high affinity and selectivity for key serotonin receptors (5-HT1A/2A/2B/7) through its combination of potent affinity and selectivity for target receptors implicated for schizophrenia and its comorbid symptoms.
  • Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) shares declined 16.7% to $2.60. The company recently appointed Errol De Souza, Ph.D., to Board of Directors.
  • MicroVision, Inc. (NASDAQ: MVIS) fell 15.4% to $22.37 after surging 47% on Monday. The technology company has cemented its position as a “meme stock” and is spiking for the second straight session based on social media momentum.
  • PQ Group Holdings Inc. (NYSE: PQG) tumbled 14.1% to $14.34 after the company reported preliminary Q1 results and announced a secondary offering of 12,500,000 shares of common stock by selling shareholders.
  • Hydrofarm Holdings Group, Inc. (NASDAQ: HYFM) fell 12.8% to $54.00. The company announced it entered into an agreement to acquire HEAVY 16 for up to $78.1 million. The company also announced the launch of a proposed public offering of common stock.
  • Medpace Holdings, Inc. (NASDAQ: MEDP) fell 12.2% to $170.63 following Q1 results.
  • Trxade Group, Inc. (NASDAQ: MEDS) fell 11.5% to $4.31 after reporting a loss for its first quarter.
  • Scienjoy Holding Corporation (NASDAQ: SJ) dipped 11% to $9.70. The company recently announced it launched NFTs on its live-streaming platforms.
  • Sphere 3D Corp. (NASDAQ: ANY) fell 10.1% to $2.0778.
  • Amkor Technology, Inc. (NASDAQ: AMKR) shares declined 9.4% to $21.67 after the company reported Q1 results and issued Q2 guidance.
  • Cadence Design Systems, Inc. (NASDAQ: CDNS) shares fell 9.1% to $131.15 after the company reported Q1 earnings results.
  • Mesoblast Limited (NASDAQ: MESO) fell 9.1% to $7.38.
  • TriNet Group, Inc. (NYSE: TNET) fell 7.4% to $78.06 after the company posted Q1 results and issued Q2 forecast.
  • InspireMD Inc (NYSE: NSPR) shares dropped 7% to $6.83.
  • Centene Corporation (NYSE: CNC) shares dropped 6.6% to $61.66 following Q1 results.
  • Tesla, Inc. (NASDAQ: TSLA) fell 4.3% to $706.47. Tesla reported better-than-expected earnings and sales for its first quarter. Production was 180,338 vehicles in the first quarter, up 76% year-over-year, while deliveries climbed 109% year-over-year to 184,877.
 

Related Articles (AAN + ALDX)

View Comments and Join the Discussion!

Posted-In: Mid-Day MoversNews Penny Stocks Small Cap Intraday Update Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com